Neuroimaging research to understand how the brains of people with body dysmorphic disorder (BDD) functioned was limited at the time of this study.
This study by Dr. Saxena and his team aimed to use positron emission tomography (PET; a form of neuroimaging using a radiotracer to measure brain activity — in this case, the radiotracer was Fluorodeoxyglucose(18F), or FDG) to measure which areas of the brain are active at rest in people with BDD.